In a parallel designed randomised placebo-controlled clinical trial , a total of 118 non-smoker individuals with type 2 diabetes and insufficient 25-hydroxyvitamin D , aged > 30 years , were recruited from the Isfahan Endocrine and Metabolism Research Centre .